Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2006;15:267-269; doi:10.1136/tc.2005.012799
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Web-only appendix
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirschhorn, N
Right arrow Articles by Shatenstein, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirschhorn, N
Right arrow Articles by Shatenstein, S
Related Collections
Right arrow Advertising and Marketing

INDUSTRY WATCH

The Philip Morris External Research Program: results from the first round of projects

N Hirschhorn1, S Aguinaga Bialous2, S Shatenstein3

1 London, UK
2 Tobacco Policy International, San Francisco, California, USA
3 GLOBALink News & Information, Montreal, Canada

Correspondence to:
Norbert Hirschhorn
115 Greencroft Gardens, London NW6 3PE, UK; bertzpoet{at}yahoo.com


ABSTRACT
Background: Philip Morris (PM) launched the Philip Morris External Research Program (PMERP) in 2000, two years after the company agreed to the dissolution of two industry-wide, external research programmes: the Council for Tobacco Research (CTR) and the Center for Indoor Air Research (CIAR). Our previous analysis of PMERP’s Request for Applications noted that PMERP’s structure, while ostensibly concerned with new product development, was remarkably similar to that of CIAR. We also found the majority of designated peer-reviewers had previous ties to the tobacco industry and the research solicitation seemed to invite mitigating evidence concerning cigarettes and constituent risks. We concluded that a prime reason for PMERP’s existence was to garner scientific credibility for PM.

Objective: To examine the grants awarded in the first round of PMERP and subsequent peer-reviewed publications.

Methods: Searches of industry documents available on the internet using PMERP and its variations as initial keywords; searches on Medline for publications from PMERP grantees.

Results: Of 153 applications, 61 proposals were funded, 36 of which generated 78 scientific publications. Of these, 65% deal specifically with the tobacco plant or constituents. Over half the researchers listed as PMERP participants had previously received or applied for tobacco funding. One internal document indicated PMERP’s objectives included gaining "credibility" and "goodwill", and finding "young scientists". In addition, PM has launched its own and more extensive internal product design research programme.

Conclusion: PMERP appears to exist less as a conduit for critical scientific inquiry than to fit into a corporate strategy intended to burnish PM’s public image.


Abbreviations: CIAR, Center for Indoor Air Research; CTR, Council for Tobacco Research; INBIFO, Institut für Biologische Forschung; PI, principal investigator; PM, Philip Morris; PMERP, Philip Morris External Research Program; RFA, Request for Applications; SAB, Science Advisory Board

Keywords: Philip Morris; external research; Philip Morris External Research Program; Center for Indoor Air Research




This article has been cited by other articles:


Home page
CirculationHome page
E. K. Tong and S. A. Glantz
Tobacco Industry Efforts Undermining Evidence Linking Secondhand Smoke With Cardiovascular Disease
Circulation, October 16, 2007; 116(16): 1845 - 1854.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
S. F Schick and S. A Glantz
Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement
Tob. Control, June 1, 2007; 16(3): 157 - 164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.